Professor Peter Johnson, NHS national cancer director (Image provided by NHS England)
Almost 113,000 people have had a fibroscan of their liver and nearly 8,500 have been referred for liver cancer checks following the…
Continue Reading
Nurses across England will be trained as ‘genomics champions’ to help patients get faster diagnoses and access treatment closer to home, as the part of the government’s 10 year health plan.
The government is creating…
This randomized trial compared remote perioperative telemonitoring (RPM) care versus surgeon only care in patients with gastrointestinal (GI), genitourinary (GU), or gynecological (GYN) cancers (N = 293). The RPM care arm wore a wristband accelerometer and…
Continue Reading
Identification of cohorts at higher risk of cancer can enable earlier diagnosis of the disease, which significantly improves patient outcomes. In this study, we select nine cancer sites with high incidence of late-stage diagnosis…
Continue Reading
Doug Stephen, President, CSG Immersive
Nurses aren’t just on the front lines of healthcare. They’re also at the front lines of emotional trauma.
Whether it’s telling a patient their cancer is terminal, helping grieving parents understand…
Continue Reading
What You Should Know:
– Tempus AI, Inc., a technology company focused on advancing precision medicine with AI, has acquired Paige, an AI company specializing in digital pathology.
– The acquisition, valued at $81.25M, paid predominantly…
Continue Reading
Cancer Awareness Trust is launching a platform in the UK to support people affected by cancer, designed in partnership with digital product studio, ustwo.
The Cancer Platform will first be piloted with prostate and breast…
What You Should Know:
– PathAI, a provider of AI and digital pathology solutions, and Moffitt Cancer Center, a top cancer hospital, have announced a multi-year strategic collaboration to deploy PathAI’s digital pathology platform, AISight®…
Continue Reading
Telehealth has been promoted as a solution to spatial healthcare access barriers, yet its role in addressing cancer care disparities remains uncertain, particularly in the context of digital divides in broadband availability and affordability….
Continue Reading
Prostate cancer (PCa) ranks among the most prevalent cancers in men worldwide. Biochemical recurrence (BCR) presents a major clinical challenge in PCa management, with significant prognostic heterogeneity observed among patients post-recurrence. This study aimed…
Continue Reading
